BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35404425)

  • 1. Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation.
    Caravaca-Fontán F; Polanco N; Villacorta B; Buxeda A; Coca A; Ávila A; Martínez-Gallardo R; Galeano C; Valero R; Ramos N; Allende N; Cruzado-Vega L; Pérez-Sáez MJ; Sevillano Á; González E; Hernández A; Rodrigo E; Fernández-Ruiz M; Aguado JM; Pérez Valdivia MÁ; Pascuall J; Andrés A; Praga M;
    Nephrol Dial Transplant; 2023 Jan; 38(1):222-235. PubMed ID: 35404425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification.
    Alasfar S; Carter-Monroe N; Rosenberg AZ; Montgomery RA; Alachkar N
    BMC Nephrol; 2016 Jan; 17():7. PubMed ID: 26754737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
    Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
    BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement Activation.
    Carrara C; Podestà MA; Abbate M; Rizzo P; Piras R; Alberti M; Daina E; Ruggenenti P; Remuzzi G;
    Nephron; 2020; 144(4):195-203. PubMed ID: 32050203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.
    Wong EKS; Marchbank KJ; Lomax-Browne H; Pappworth IY; Denton H; Cooke K; Ward S; McLoughlin AC; Richardson G; Wilson V; Harris CL; Morgan BP; Hakobyan S; McAlinden P; Gale DP; Maxwell H; Christian M; Malcomson R; Goodship THJ; Marks SD; Pickering MC; Kavanagh D; Cook HT; Johnson SA;
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1639-1651. PubMed ID: 34551983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment.
    Noris M; Daina E; Remuzzi G
    Nephrol Dial Transplant; 2023 Feb; 38(2):283-290. PubMed ID: 34596686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
    Ruggenenti P; Daina E; Gennarini A; Carrara C; Gamba S; Noris M; Rubis N; Peraro F; Gaspari F; Pasini A; Rigotti A; Lerchner RM; Santoro D; Pisani A; Pasi A; Remuzzi G;
    Am J Kidney Dis; 2019 Aug; 74(2):224-238. PubMed ID: 30929851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranoproliferative glomerulonephritis: current histopathological classification, clinical profile, and kidney outcomes.
    Bernardes TP; Mastroianni-Kirsztajn G
    J Bras Nefrol; 2023; 45(1):45-50. PubMed ID: 35789244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of glomerular diseases with a membranoproliferative glomerulonephritis (MPGN) pattern of injury].
    Rudnicki M; Windpessl M; Eller K; Odler B; Gauckler P; Neumann I; Zitt E; Regele H; Kronbichler A; Lhotta K; Säemann MD
    Wien Klin Wochenschr; 2023 Aug; 135(Suppl 5):688-695. PubMed ID: 37728653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Membranoproliferative Glomerulonephritis After Kidney Transplantation: Risk Factors and Impact on Graft Survival.
    de Paula LC; Mazzali M; de Sousa MV
    Ann Transplant; 2023 Jul; 28():e940502. PubMed ID: 37461201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
    Holle J; Berenberg-Goßler L; Wu K; Beringer O; Kropp F; Müller D; Thumfart J
    Pediatr Nephrol; 2018 Dec; 33(12):2289-2298. PubMed ID: 30238151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy.
    Kovala M; Seppälä M; Räisänen-Sokolowski A; Meri S; Honkanen E; Kaartinen K
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
    Noris M; Donadelli R; Remuzzi G
    Pediatr Nephrol; 2019 Aug; 34(8):1311-1323. PubMed ID: 29948306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of recurrent membranoproliferative glomerulonephritis after kidney transplantation due to ventriculoatrial shunt infection.
    Völker LA; Burkert K; Scholten N; Grundmann F; Kurschat C; Benzing T; Hampl J; Becker JU; Müller RU
    BMC Nephrol; 2019 Aug; 20(1):296. PubMed ID: 31382904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center.
    Nakano M; Karasawa K; Moriyama T; Uchida K; Nitta K
    Clin Exp Nephrol; 2019 Jun; 23(6):852-858. PubMed ID: 30854618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis.
    Angelo JR; Bell CS; Braun MC
    Am J Kidney Dis; 2011 Feb; 57(2):291-9. PubMed ID: 21215503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulopathy in Japanese children.
    Ueda C; Horinouchi T; Inoki Y; Ichikawa Y; Tanaka Y; Kitakado H; Kondo A; Sakakibara N; Nagano C; Yamamura T; Fujimura J; Kamiyoshi N; Ishimori S; Ninchoji T; Kaito H; Shima Y; Iijima K; Nozu K; Yoshikawa N
    Pediatr Nephrol; 2024 Apr; ():. PubMed ID: 38662234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the understanding of complement mediated glomerular disease: implications for recurrence in the transplant setting.
    Barbour S; Gill JS
    Am J Transplant; 2015 Feb; 15(2):312-9. PubMed ID: 25612487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent membranoproliferative glomerulonephritis after kidney transplantation.
    Lorenz EC; Sethi S; Leung N; Dispenzieri A; Fervenza FC; Cosio FG
    Kidney Int; 2010 Apr; 77(8):721-8. PubMed ID: 20130531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.